Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic
  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

InvestorNewsBreaks – Endexx Corp. (EDXC) Announces Its Blesswell Brand Now Available at Select CVS Health Stores

Endexx Corp. (OTC: EDXC) has announced that its Blesswell(TM) Skincare Line can now be found on the shelves of CVS health stores. Endexx is a provider of innovative hemp-derived CBD (“cannabidiol”) wellness and health products, and the Blesswell brand, a CBD-infused men’s grooming and skin care line, was unveiled last year; the line is focused on maximizing accessibility to CBD wellness products. According to the announcement, three Blesswell facial products — the Blue Charcoal Clay Mask, the Daily Moisturizer and the Facial Cleaning Scrub — are now available for purchase at select CVS Health stores as well as on the CVS online retail portal. Blesswell is an eco-friendly, clean, cannabis-minded line of products that features an array of offerings, including beard oils, shaving cream, face cleansers, and body washes, with each infused with 300 mg CBD. “This is an incredible branding and expansion opportunity for Blesswell and its product line,” said  Endexx CEO Todd Davis in the press release. “Having Blesswell products available at CVS for customers to purchase bolsters our national presence. We are honored to join forces with the retailer as they expand upon their health and wellness initiatives.”

To view the full press release, visit https://ibn.fm/ufCkP 

About Endexx Corporation 

Endexx Corporation, through its operating division CBD Unlimited, develops and distributes all-natural CBD products derived from the cannabis sativa plant (hemp) containing less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products — all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The science behind these products involves more than half a decade of clinical research in the field and lab work to provide accuracy in dosage and delivery of optimal absorption per serving. For more information about the company, please visit www.Endexx.com.

NOTE TO INVESTORS: The latest news and updates relating to EDXC are available in the company’s newsroom at https://ibn.fm/EDXC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.